Literature DB >> 10431212

Spinal systems and pain processing: development of novel analgesic drugs with mechanistically defined models.

T L Yaksh1.   

Abstract

Much research has been undertaken in the field of pain in an attempt to find an effective treatment. Insights into the underlying mechanisms of pain have been gained from studies using preclinical animal models (acute stimuli, post-tissue injury and peripheral nerve injury) and evaluating their similarity with the human condition. In this article, these pain models are summarized and the mechanisms of pain discussed in relation to spinal processing. In the context of this research the therapeutic potential of novel analgesics is highlighted as the future looks forward to the many possibilities that the targeted spinal delivery of drugs can bring.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10431212     DOI: 10.1016/s0165-6147(99)01370-x

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  29 in total

1.  Antihyperalgesic effects of loperamide in a model of rat neuropathic pain are mediated by peripheral delta-opioid receptors.

Authors:  Katsumi Shinoda; Victor J Hruby; Frank Porreca
Journal:  Neurosci Lett       Date:  2006-11-15       Impact factor: 3.046

2.  Intrathecal huperzine A increases thermal escape latency and decreases flinching behavior in the formalin test in rats.

Authors:  Paula Park; Steven Schachter; Tony Yaksh
Journal:  Neurosci Lett       Date:  2009-12-22       Impact factor: 3.046

3.  Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions.

Authors:  Zhen-Zhong Xu; Ling Zhang; Tong Liu; Jong Yeon Park; Temugin Berta; Rong Yang; Charles N Serhan; Ru-Rong Ji
Journal:  Nat Med       Date:  2010-04-11       Impact factor: 53.440

4.  Altered pain responses in mice lacking alpha 1E subunit of the voltage-dependent Ca2+ channel.

Authors:  H Saegusa; T Kurihara; S Zong; O Minowa; A Kazuno; W Han; Y Matsuda; H Yamanaka; M Osanai; T Noda; T Tanabe
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

5.  Selective downregulation of hepatic cytochrome P450 expression and activity in a rat model of inflammatory pain.

Authors:  Denis Projean; Sophie Dautrey; Huy Khan Vu; Thierry Groblewski; Jean-Louis Brazier; Julie Ducharme
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

6.  Antagonism of the melanocortin system reduces cold and mechanical allodynia in mononeuropathic rats.

Authors:  D H Vrinten; W H Gispen; G J Groen; R A Adan
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

7.  Identification of MEK1 as a novel target for the treatment of neuropathic pain.

Authors:  A Ciruela; A K Dixon; S Bramwell; M I Gonzalez; R D Pinnock; K Lee
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

8.  Semi-mechanistic modelling of the analgesic effect of gabapentin in the formalin-induced rat model of experimental pain.

Authors:  A Taneja; I F Troconiz; M Danhof; O Della Pasqua
Journal:  Pharm Res       Date:  2013-10-05       Impact factor: 4.200

Review 9.  Translational pain research: achievements and challenges.

Authors:  Jianren Mao
Journal:  J Pain       Date:  2009-07-22       Impact factor: 5.820

10.  Comparative anti-inflammatory properties of Capsaicin and ethyl-aAcetate extract of Capsicum frutescens linn [Solanaceae] in rats.

Authors:  A T Jolayemi; J A O Ojewole
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.